Assessment of allergic status of severe asthma with a new component resolved method using micro-array technique

C. Mailhol, P.A. Apoil, A. Blancher, A. Didier (Toulouse, France)

Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Session: Recent progress in mechanisms and diagnostics of COPD and asthma
Session type: Poster Discussion
Number: 1760
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Mailhol, P.A. Apoil, A. Blancher, A. Didier (Toulouse, France). Assessment of allergic status of severe asthma with a new component resolved method using micro-array technique. Eur Respir J 2012; 40: Suppl. 56, 1760

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Two novel, severe asthma phenotypes identified during childhood using a clustering approach
Source: Eur Respir J 2012; 40: 55-60
Year: 2012



Improved definition of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013


Quantitative analysis of severe asthma exacerbation requiring continuous inhalation therapy by measurements of modified pulmonary index score
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013


Diagnostic approach to and phenotyping of severe asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017


Capability of classical diagnostic procedure in relation with specific inhalation challenge for conclusive diagnosis in allergic asthma
Source: Annual Congress 2008 - Asthma and inhalation injuries at work
Year: 2008

Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score.
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018
Year: 2018



Omalizumab significantly improves quality of life in patients with severe persistent allergic asthma: a pooled analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 49s
Year: 2005

CompEx – A novel composite asthma exacerbation endpoint
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015


Non-drug methods in complex treatment of the severe bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002

Is it really severe asthma? A systematic approach to assessment
Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Year: 2019


Development of an integrated allergic rhinitis and asthma model with partial immunological tolerance
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009

Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Development of a novel prediction model for acute asthma exacerbation
Source: International Congress 2018 – Asthma management
Year: 2018

Efficacy of Omalizumab in adult and pediatric severe allergic asthma according to presence of multiple allergic comorbidities: evidence from the STELLAIR study.
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Combining digital technologies to monitor asthma control and predict asthma exacerbations
Source: Virtual Congress 2020 – Digital health: a brave new world?
Year: 2020


A novel evaluation of the impact of severe allergic asthma in children: The family perspective
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010

Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
Source: ERJ Open Res, 7 (1) 00828-2020; 10.1183/23120541.00828-2020
Year: 2021